ADTN vs YB

ADTN's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with mixed profitability signals and a lack of Altman Z-Score data raising caution. The company shows strong revenue growth (20.1% YoY) and recent EPS rebound, but persistent negative ROE and ROA, along with a negative profit margin, highlight ongoing operational inefficiencies. Despite a favorable price-to-sales ratio (0.74) and a forward P/E of 13.11, the absence of a Graham Number and intrinsic value estimate limits fundamental valuation clarity. Analysts maintain a 'buy' recommendation with a $14.00 target, suggesting optimism, though insider selling and weak recent earnings surprises temper conviction.

YB exhibits a stable financial profile with a Piotroski F-Score of 6/9 and an exceptionally clean balance sheet featuring zero debt. The stock is severely undervalued, trading at $17.35, which is significantly below both its Graham Number ($31.22) and its growth-based Intrinsic Value ($118.59). While technical trends are currently bearish and insider sentiment is weak, the combination of a 4.32 P/E ratio, 96% gross margins, and 30%+ growth rates presents a compelling deep-value opportunity.